Clinical trial
Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study
NCT00676559 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- April 30, 2008
- Completion date
- April 30, 2010
- Enrollment
- 0 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema